https://www.googletagmanager.com/gtag/js?id=UA-173161930-1">
Home
About
Overview
Management Team
Board of Directors
R&D
Product Portfolio
Therapeutic Areas
News & Investors
Overview
Press Releases
Events
Presentations
Governance
Stock Info
Financial & Filings
Contact
Careers
All SEC Filings
News & Investors
News & Investors
Overview
Press Releases
Events
Presentations
Governance
Governance Documents
Board of Directors
Board Committees
Stock Info
Form 8937
Financial & Filings
Overview
All SEC Filings
Financial & Filings
Overview
All SEC Filings
Filing Type:
View All
10-12B
10-12B/A
10-K
10-Q
25-NSE
3
4
424B3
424B4
424B5
8-A12G
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
04/02/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
04/02/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
03/30/20
4
Statement of changes in beneficial ownership of securities
2
03/27/20
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
5
03/27/20
DEF 14A
Definitive proxy statements
43
03/27/20
4
Statement of changes in beneficial ownership of securities
2
03/27/20
4
Statement of changes in beneficial ownership of securities
2
03/26/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
03/24/20
424B5
Prospectus filed pursuant to Rule 424(b)(5)
62
03/24/20
8-K
Current report filing
Documents
EX-1.1
EX-4.1
EX-4.2
EX-5.1
EX-99.1
111
Previous
1…
25
26
27
28
29
30
31
32
33
34
…36
Next
Email Alerts
Tear Sheet
RSS News Feed